🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

CybinInc was honored to participate in the 28th Annual Milken Institute Global Conference on May 5th, 2025, where CEO Doug Drysdale discussed the role of innovation in realizing new standards of care for the treatment of mental health as part of a panel discussion on the Global

“Securing an additional patent in support of CYB003 provides important validation of our program and reinforces the commercial potential of our pipeline,” said #Cybin CEO Doug Drysdale Learn more: loom.ly/4r6Nng0 #MentalHealth #BreakthroughTherapy

#cybin CEO Doug Drysdale will be the featured speaker at the Business Track during the Psychedelic Science 2025 conference in Denver, Colorado, from June 16-20, 2025. globenewswire.com/news-release/2…

Join #Cybin CEO Doug Drysdale for a fireside chat next week at the virtual Alliance Global Partners Healthcare Company Showcase. Tune in at 1:40 p.m. ET on Wednesday, May 21, 2025! Register for the webcast here: loom.ly/YNUXw7E

Proud to partner with Thermo Fisher Scientific for the U.S. manufacturing of CYB003. “This is an exciting time for Cybin as we focus on the execution of our Phase 3 CYB003 pivotal program,” said #Cybin CEO Doug Drysdale. Learn more: loom.ly/4r6Nng0

Today, Cybinauts are wearing green to unmask mental health by fostering open discussion and challenging stigma, while reaffirming our commitment to novel, next-generation therapies for patients in need. #WearItGreenDay #MentalHealthInnovation #BreakthroughTherapy

Cybin Inc expands Phase 3 and commercialization readiness with new Thermo Fisher partnership. 🔹 Thermo Fisher to manufacture CYB003 for Phase 3 and potential commercialization at US sites — tariff-protected 🔹 Builds on recent Osmind partnership to access 800+ psychiatry

Standing together on the International Day Against Homophobia to advocate for mental health and inclusivity for all. Let's build a world of understanding and support. 🌈 🌏 #IDAHOT #MentalHealthForAll

“It is gratifying that the U.S. FDA Commissioner Dr. Martin Makary shares our belief in the potential therapeutic value of these innovative treatments – a long-held belief that stands at the core of Cybin’s mission,” said Doug Drysdale, Chief Executive Officer of Cybin. Watch Dr.

Please join Robert Sassoon for a fireside chat with CybinInc Chief Executive Officer Doug Drysdale on Thursday, May 29, 2025, at 11:00 am ET. Register below! us06web.zoom.us/webinar/regist… $CYBN #FiresideChat #Psychedelics #SmallCap #Stocks #Investing

#Cybin CEO Doug Drysdale will discuss partnerships, progress on #CYB003, upcoming milestones, and the #FDA and #psychedelics in a Water Tower Research LLC Fireside Chat next week, Thursday, May 29, 2025. Click here to register for the webcast: loom.ly/ORTJqz4

“On this Memorial Day, I pause to honor the brave men and women who made the ultimate sacrifice for our freedom. Their courage and selflessness are the foundation upon which we build our mission to transform mental health care. The freedoms they secured allow us to innovate,

#AlphaNooner - Inside Cybin with CEO Doug Drysdale $CYBN x.com/i/broadcasts/1…

#PARADIGM, Cybin’s Phase 3 program evaluating CYB003 for the adjunctive treatment of Major Depressive Disorder (#MDD), comprises two 12-week randomized, placebo-controlled studies (APPROACH and EMBRACE) and a long-term extension study (EXTEND). Learn more: cybin.com/development-pi…

#ICYMI: Last week, Cybin CEO Doug Drysdale was featured in a fireside chat hosted by Jim Molloy at Alliance Global Partners (A.G.P.)'s Virtual Healthcare Showcase. Tune in to the replay to learn more about Cybin's progress with its lead clinical-stage programs CYB003 and CYB004,

Today on Tomi Lahren is Fearless: - Power of Psychedelics - Ketamine Benefits - Cybin CEO Doug Drysdale Joins - Big Pharma Breakthrough? - Symptom vs Cause? - Tricking Mental Illness x.com/i/broadcasts/1…